XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
Conditions
- Carcinoma
- Gastrointestinal Diseases
- Stomach Cancer
- Gastroesophageal-junction Cancer
- Digestive System Diseases
- Gastric Cancer
- Gastrointestinal Neoplasms
Interventions
- DRUG: Anlotinib hydrochloride capsule
- DRUG: Penpulimab Injection
- DRUG: XELOX
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborators